Alnylam Pharmaceuticals
ALNY
#579
Rank
C$48.11 B
Marketcap
$374.81
Share price
1.16%
Change (1 day)
59.18%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividends for this company